Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nvidia Corp (NVDA)

Nvidia Corp (NVDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Nvidia Dumped Recursion Pharmaceuticals Stock. Should You?

When artificial intelligence (AI) chip maker NVIDIA Corporation (NVDA) heads for the exit, investors instinctively glance at the door. In its latest 13F filing, the chip giant disclosed that it had completely exited its position in the AI-driven drug developer Recursion Pharmaceuticals (RXRX).

At the end of Q3 2025, Nvidia held 7.71 million shares. The stake represented a modest slice of its expansive, meticulously managed AI portfolio. Still, the headline carried weight. Traders pushed the stock down as much as 14% during the session before buyers regrouped and lifted it to a nearly 2% gain by the close of Wednesday, Feb 18.

Fundamentals

See More
  • Market Capitalization, $K 4,567,913,920
  • Shares Outstanding, K 24,300,000
  • Annual Sales, $ 130,497 M
  • Annual Income, $ 72,880 M
  • EBIT $ 110,121 M
  • EBITDA $ 111,985 M
  • 60-Month Beta 2.31
  • Price/Sales 24.69
  • Price/Cash Flow 60.49
  • Price/Book 37.80

Options Overview Details

View History
  • Implied Volatility 48.93% (-0.73%)
  • Historical Volatility 36.23%
  • IV Percentile 71%
  • IV Rank 39.79%
  • IV High 74.95% on 04/08/25
  • IV Low 31.73% on 06/24/25
  • Expected Move (DTE 1) 2.55 (1.36%)
  • Put/Call Vol Ratio 0.66
  • Today's Volume 1,797,541
  • Volume Avg (30-Day) 2,440,881
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 15,778,613
  • Open Int (30-Day) 15,077,392
  • Expected Range 185.35 to 190.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 50 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/26
See More
  • Average Estimate 1.45
  • Number of Estimates 15
  • High Estimate 1.48
  • Low Estimate 1.42
  • Prior Year 0.85
  • Growth Rate Est. (year over year) +70.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
171.03 +9.86%
on 02/05/26
194.49 -3.39%
on 01/30/26
+1.67 (+0.90%)
since 01/16/26
3-Month
169.55 +10.82%
on 11/25/25
196.00 -4.13%
on 11/20/25
+1.38 (+0.74%)
since 11/19/25
52-Week
86.62 +116.92%
on 04/07/25
212.19 -11.45%
on 10/29/25
+48.67 (+34.96%)
since 02/19/25

Most Recent Stories

More News
US stocks slip as AI fears keep rumbling and oil prices climb

U.S. stocks fell, while oil prices climbed

APO : 118.34 (-5.60%)
META : 644.78 (+0.24%)
NVDA : 187.90 (-0.04%)
ARES : 129.85 (-3.08%)
OWL : 11.58 (-5.93%)
$SPX : 6,861.89 (-0.28%)
$IUXX : 24,797.34 (-0.41%)
ETSY : 48.14 (+9.28%)
EBAY : 84.75 (+3.13%)
CVNA : 332.79 (-7.95%)
$DOWI : 49,395.16 (-0.54%)
MRNA : 49.70 (+6.65%)
Nvidia Dumped Recursion Pharmaceuticals Stock. Should You?

Nvidia sold its position in Recursion Pharmaceuticals, while others keep a measured outlook. Does this divergence signal risk or opportunity?

NVDA : 187.90 (-0.04%)
RXRX : 3.72 (+5.38%)
ARKK : 72.24 (+1.19%)
As Apple Tests AI Devices, Should You Buy AAPL Stock Here?

As Apple ramps up its AI ambitions through consumer-focused devices, is now the perfect time to grab AAPL before its next growth wave begins?

NVDA : 187.90 (-0.04%)
AAPL : 260.58 (-1.43%)
$SPX : 6,861.89 (-0.28%)
Super Micro Computer Stock Is Pushing Above Its 50-Day Moving Average. Should You Buy SMCI Here?

Supermicro shares inched higher on a significant increase in bullish options activity. Here’s why SMCI stock is likely undervalued at current levels.

NVDA : 187.90 (-0.04%)
SMCI : 32.16 (+8.25%)
Billionaire Hedge Fund Tiger Global Is Betting Big on This 1 Stock

Billionaire investor Chase Coleman’s Tiger Global Management is doubling down on newly public Wealthfront, while trimming mega-cap tech holdings, a bold signal of conviction.

MSFT : 398.46 (-0.29%)
WLTH : 8.84 (-4.43%)
NVDA : 187.90 (-0.04%)
AMZN : 204.86 (+0.03%)
Why Nvidia Just Made a $7.9 Billion Bold Bet on Intel

Nvidia just invested billions in Intel. Is this a buy signal for INTC stock?

NVDA : 187.90 (-0.04%)
INTC : 44.62 (-1.85%)
$SPX : 6,861.89 (-0.28%)
SFTBY : 14.3089 (+0.77%)
QQQ Just Sent a Chilling Signal — Right Before Nvidia Earnings

The QQQ is showing a crack in its foundation. Here's what it means, how you should play it, and what to expect from Nvidia earnings next week.

QQQ : 603.47 (-0.38%)
NVDA : 187.90 (-0.04%)
$SPX : 6,861.89 (-0.28%)
DIA : 494.38 (-0.53%)
1 Data Center Stock That Billionaire Philippe Laffont Is Buying Now

A marquee fund’s new stake highlights how essential data-center plumbing is becoming in the AI arms race.

NVDA : 187.90 (-0.04%)
VRT : 243.06 (-0.06%)
Stocks Retreat on AI Concerns and Geopolitical Risks

The S&P 500 Index ($SPX ) (SPY ) today is down -0.44%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.66%. March E-mini S&P futures...

AMAT : 369.83 (+0.14%)
DE : 662.00 (+11.58%)
TAP : 48.35 (-4.86%)
$IUXX : 24,797.34 (-0.41%)
DASH : 176.19 (+1.62%)
ZNH26 : 112-310s (+0.01%)
ESH26 : 6,877.00s (-0.25%)
QCOM : 141.27 (-1.38%)
STX : 408.97 (-3.58%)
WDC : 284.67 (-4.01%)
W : 79.57 (-13.02%)
LRCX : 237.39 (-1.12%)
Is It Too Early To Freak Out About Nvidia Earnings? No, And Here’s Why.

All eyes will be on Nvidia next week when the company reports Q4 earnings. Here's what to watch.

NVDA : 187.90 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NVIDIA Corporation is the worldwide leader in visual computing technologies and the inventor of the graphic processing unit, or GPU. Over the years, the company's focus has evolved from PC graphics to artificial intelligence (AI) based solutions that now support high performance computing (HPC), gaming...

See More

Key Turning Points

3rd Resistance Point 191.77
2nd Resistance Point 190.10
1st Resistance Point 189.00
Last Price 187.90
1st Support Level 186.23
2nd Support Level 184.56
3rd Support Level 183.46

See More

52-Week High 212.19
Last Price 187.90
Fibonacci 61.8% 164.22
Fibonacci 50% 149.40
Fibonacci 38.2% 134.59
52-Week Low 86.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar